July 2002 (Series A): CHF15.8 million ($10.5M / €10M)
May 2004 (Series B): CHF50.5 million ($39M / €33M)
Sep 2006 (Series C): CHF40.0 million ($32M / €25M)
May 2007 (IPO): CHF137 million ($111M / €83M)
Sofinnova Partners: www.sofinnova.fr
Index Ventures: www.indexventures.com
Techno Venture Capital: www.tvm-capital.com
PolyTechnos Venture-Partners: www.polytechnos.com
Bio*One Capital: www.biomed-Singapore.com
Vinci Capital - Renaissance PME: www.vincicapital.ch, www.renaissance-pme.ch
BCV Initiative Capital: www.bcv.ch
Fulcrum Pharma Development Plc: www.fulcrumpharma.com
SR One (GlaxoSmithKline): www.srone.com
Roche Venture Fund: www.roche.com